StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | VKTX Viking Therapeutics | $29.44 | +3.66% | $3.3B | — | — | — | — | 50 |
| 1 | TWST Twist Bioscience | $53.66 | +8.40% | $3.1B | — | 7.5 | +17.8% | 52.1% | 60 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $45.19 |
| +8.40% |
| $3.3B |
| 37.8 |
| 6.1 |
| +16.9% |
| 70.9% |
| 53 |
| 3 | ACAD Acadia Pharmaceuticals | $20.95 | +2.29% | $3.5B | 9.0 | 4.2 | -13.6% | 91.7% | 44 |
| 4 | ERAS ERAS | $11.12 | +7.75% | $3.2B | — | — | — | — | — |
| 5 | TNGX TNGX | $21.08 | +3.84% | $2.9B | — | 44.2 | +48.3% | — | — |
| 6 | DNLI DNLI | $18.83 | +3.98% | $2.9B | — | 8.4 | — | — | — |
| 7 | RCUS RCUS | $23.74 | +4.35% | $2.9B | — | 12.2 | -15.1% | — | — |
| 8 | DYN DYN | $17.56 | +10.30% | $2.6B | — | — | — | — | — |
| 9 | GRAL GRAL | $66.03 | +8.26% | $2.6B | — | 16.8 | +19.4% | 49.3% | — |